Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 2
1992 2
1993 2
1994 1
1997 1
1998 1
1999 3
2000 1
2002 2
2004 2
2006 1
2007 4
2008 4
2009 2
2010 1
2011 5
2012 2
2013 6
2014 2
2016 1
2017 1
2018 2
2019 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Dabigatran versus warfarin in patients with atrial fibrillation.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators. Connolly SJ, et al. N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. N Engl J Med. 2009. PMID: 19717844 Free article. Clinical Trial.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Thai clinical trials registry.
Tulvatana W, Kulvichit K, Thinkhamrop B, Tatsanavivat P. Tulvatana W, et al. Among authors: tatsanavivat p. J Evid Based Med. 2011;4(3):182-4. doi: 10.1111/j.1756-5391.2011.01148.x. J Evid Based Med. 2011. PMID: 23672723
Prevalence of cardiac arrhythmias in Thai community.
Kiatchoosakun S, Pachirat O, Chirawatkul A, Choprapawan C, Tatsanavivat P. Kiatchoosakun S, et al. Among authors: tatsanavivat p. J Med Assoc Thai. 1999 Jul;82(7):727-33. J Med Assoc Thai. 1999. PMID: 10511776
The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.
Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators. Do R, et al. PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11. PLoS Med. 2011. PMID: 22022235 Free PMC article.
Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors.
Phababpha S, Kukongviriyapan U, Pakdeechote P, Senggunprai L, Kukongviriyapan V, Settasatian C, Tatsanavivat P, Intharaphet P, Senthong V, Komanasin N, Settasatian N, Greenwald SE. Phababpha S, et al. Among authors: tatsanavivat p. Cardiovasc Diabetol. 2013 Jun 21;12:93. doi: 10.1186/1475-2840-12-93. Cardiovasc Diabetol. 2013. PMID: 23787071 Free PMC article.
National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018.
Sakboonyarat B, Pima W, Chokbumrungsuk C, Pimpak T, Khunsri S, Ukritchon S, Imjaijitt W, Mungthin M, Kaewput W, Bhopdhornangkul B, Sathavarodom N, Tatsanavivat P, Rangsin R. Sakboonyarat B, et al. Among authors: tatsanavivat p. Sci Rep. 2021 Jul 12;11(1):14260. doi: 10.1038/s41598-021-93733-4. Sci Rep. 2021. PMID: 34253809 Free PMC article.
51 results